Florida / New York

Ph: 561.316.3330

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States

Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.

Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve.

Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.

"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"

Terumo Neuro Celebrates 15 Years of the WEB Device: A Game-Changing Innovation in Aneurysm Treatment

Carsten Schroeder, President and CEO of Terumo Neuro, commented on this significant milestone: “The WEB device has set a new standard in aneurysm treatment and has been instrumental in our mission to drive game-changing impact in neurovascular care. With 15 years of proven clinical success, WEB continues to advance patient outcomes, reducing the need for multiple devices and lengthy procedures. As we celebrate this achievement, we remain committed to innovating alongside leading physicians worldwide to shape the future of neurovascular care.”

Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding

Carl Marks Securities Successfully Advises Kewaunee Scientific Corporation on $55 Million Acquisition of Nu Aire

“We have maintained an advisory relationship with Kewaunee for many years and are proud to have played a role in the successful strategic acquisition of Nu Aire by Kewaunee,” added Evan Tomaskovic, Managing Partner at Carl Marks Advisors. “It is gratifying to assist a 100-year-old business complete a key acquisition of a more than 50-year-old family-owned business, fortifying the legacies of both world-class organizations.”

Bright Uro Announces Oversubscribed $32M Series A Funding Round

Derek Herrera, founder and CEO of Bright Uro. “With this funding, we are well resourced for the launch of Glean in 2025, while also continuing to resource our pipeline of innovation. We have never been more confident in the expected impact Glean will have for clinicians and millions of patients suffering from urinary issues.”

Industry Expert Byline

FDA Medical Device Updates

Co-Diagnostics Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

The decision by Co-Diagnostics to withdraw the submission was based on discussions with the FDA regarding the ability to detect a potential deterioration of one component of the test, related to shelf-life stability. Following dialogue with the FDA and exploring the various courses of action available, Co-Dx has determined that the best long-term solution would be to submit a version of the test that has been enhanced to address the matter raised in the 510(k) review process. 

Our Experts - Byline Articles

Advancements in Imaging

Lunit’s AI-Powered Mammography Analysis Solution Achieves Comparable Diagnostic Performance with Human Readers

“This first study to apply the Personal Performance in Mammographic Screening (PERFORMS) scheme to AI algorithms marks a remarkable achievement, showcasing our AI’s ability to match human performance in detecting breast cancer. It offers hope to patients worldwide and underscores AI’s potential to enhance cancer detection and treatment outcomes,” said Brandon Suh, CEO of Lunit.

PENTERO Platform

ZEISS Reimagined the Iconic PENTERO Platform for Today’s Digital Age

“The iconic ZEISS PENTERO platform is one of the most widely used surgical microscopes around the world with more than 20 million surgical procedures to date. With the surgeons’ constantly evolving discipline-specific challenges in mind, ZEISS now reimagined it for today’s digital age to support them in elevating the microsurgical interventions to yet another level,” says Magnus Reibenspiess, Head of Strategic Business Unit Microsurgery, ZEISS Medical Technology.

Hospitals In the News

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Healthcare - Understanding the Business Side of the Industry and Its Implications

Healthcare Careers and Opportunities

In the Evolving Medical Field

Nurses Corner

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.